Penumbra, Inc. (PEN)

Penumbra, Inc. (PEN) is a healthcare company (medical devices) based in the United States. The share price is $319.76, down 0.27% on the day, which values the company at $12.6B. Price as of 17 Nov 2026, 17:16 UTC, from Yahoo Finance.

Key facts

Share price
$319.76−0.27% today
Market value
$12.6B
P/E ratio
80.5×last 12 months
Forward P/E
52.7×
Funk Score
76/100
Against its own history
Below its usual priceusual price $388.46
200-week average
$268.0919% above
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Penumbra, Inc. in more detail

PEN trades at 80.5× its last twelve months' earnings, 52.7× next year's expected earnings, 8.1× sales. Measured against its own history, the price is 18% below what its usual multiples would imply ($388.46) — below its usual price. It sits 19% above its 200-week average of $268.09.

Over the last five fiscal years Penumbra, Inc. has compounded revenue 20.2% a year. Its Funk Score is 76 out of 100 (financial strength 9.5, profitability 6.8, growth 9.8, value 4.2, each out of 10).

In its favour: Altman Z in the safe zone; Strong Piotroski score. Worth checking: Share count keeps rising.

2 of the superinvestors tracked here hold PEN, including Paul Tudor Jones (0.5% of the portfolio), Israel Englander (0.1% of the portfolio).

Superinvestors holding PEN

2 of the investors tracked here report a position in their latest 13F filing.

Compare

Health Care companies of similar size

Side by side:PEN vs RDY (Penumbra, Inc. vs Dr. Reddy's Laboratories)PEN vs ALGN (Penumbra, Inc. vs Align Technology)PEN vs SNN (Penumbra, Inc. vs Smith & Nephew)PEN vs COO (Penumbra, Inc. vs Cooper Companies)PEN vs ELAN (Penumbra, Inc. vs Elanco Animal Health)

All health care companies by market valueLargest companies in the United StatesAll stocks A–Z

Penumbra, Inc. (PEN): questions and answers

What is PEN's P/E ratio?

Penumbra, Inc. trades at 80.5× its last twelve months' earnings and 52.7× next year's expected earnings. At its fiscal year-ends over the past 4 years the P/E ranged from 68.8× to 145.0×, with a median of 115.5×.

What is PEN's PEG ratio?

Penumbra, Inc.'s PEG ratio is 3.62 — its P/E divided by its expected earnings growth. Around 1 is the classic sign of a price that matches the growth; well above it means the growth is being paid for in advance.

What is Penumbra, Inc.'s market cap?

Penumbra, Inc. is valued at $12.6B at a share price of $319.76.

Is PEN overvalued or undervalued?

Against its own history, PEN is below its usual price: the price is 18% below the $388.46 implied by the median multiples it has traded at (price / earnings, price / sales, price / book, price / free cash flow). That compares the stock with its past; it does not say whether the business now deserves a higher or lower multiple.

Is PEN above its 200-week moving average?

Yes. PEN is 19.3% above its 200-week average of $268.09. Long-term investors watch that line because strong companies rarely trade below it for long.

How fast is Penumbra, Inc. growing?

Over the last five fiscal years Penumbra, Inc.'s revenue grew 20.2% a year; over ten years revenue grew 22.4% a year.

Cite this page

Funkfolio, “Penumbra, Inc. (PEN) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/PEN

Underlying data: Yahoo Finance; company filings with the SEC.